Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Key Record Dates Identifier: NCT02160015
Brief Title: Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery

First Submitted : May 30, 2014
First Submitted that Met QC Criteria : June 6, 2014
First Posted : June 10, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : December 9, 2019
Last Update Posted : December 10, 2019